Three months after Turing Pharmaceuticals entered the spotlight by buying the rights to a generic drug used to save lives and dramatically increased the price from $13.50 to $750, the company’s CEO has been arrested in a securities-fraud investigation. However, the charges are related to another company the man once led. [More]
